EORTC on the future of cancer research at ECCO 2017

19/01/2017

World experts to discuss future methods in cancer research at EORTC ECCO workshop

Our workshop on the Future of Cancer Clinical Research & Therapy will bring together world experts Elizabeth Eisenhauer (Queen’s University, Canada), Stefan Sleijfer (Erasmus University, Netherlands) and Jorge Camarero (European Medicines Agency), to discuss “The regulatory and methodological dimensions of long term efficacy: PFS2 and looking beyond the first progression”.

This discussion will be followed by a session on “Registries and the external validity of clinical trials” with Gemma Gatta (Istituto Nazionale Tumori di Milano), Sabine Siesling (University of Twente, Netherlands) and Harlinde De Schutter (Belgian Cancer Registry).

Poster sessions

In addition, EORTC will be presenting two posters at the European Cancer Congress (ECCO 2017) in Amsterdam (January 27-30, 2017).

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data for Cancer Clinical Trials – SISAQOL consortium (Abstract 1333)

Session 226: Poster in the Spotlight II; Saturday 28.01.2017 – 4:00 PM – 5:00 PM
Location: Poster Area, Hall 1
Author: SISAQOL consortium


Update of the international prognostic classification for first line metastatic germ-cell cancers. An international initiative (Abstract 2197)

Session 255: Poster in the Spotlight IV; Sunday 29.01.2017 – 4:00 PM – 4:50 PM
Location: Poster Area, Hall 1
Author: L. Collette

Oral Presentations

Innovative methodology to optimise translation of trial outcome to real-world patients

Changing Practice Session: The Value of Cancer Registries; Sunday 29.01.2017 – 11:30 AM
Location: Room Zur Hausen
Speaker: L. Liu


Incorporating real-life data into drug development: towards more pragmatic trials

Changing Practice Session: External Validity of Clinical Trials; Monday 30.01.2017 – 10:35 AM
Location: Room Folkman
Speaker: M. Mauer

 

Facebooktwitterlinkedinmail

Find us

Avenue Emmanuel Mounier, 83/11
Brussels 1200
Belgium

Contact us

Follow us

Funding